Buy Like Buffett
Watchlist

EASTMAN CHEMICAL CO

EMN · Materials · $15.3B mkt cap · FY2025 filings · No moat ·

Doesn't clear the bar

No moat
Share / Embed this score
Embed this score

The five investor questions

26

2021–2025 (latest 5 aligned FYs; v3 window cap 5): revenue $10.5B to $8.8B, decreasing; diluted EPS 6.25 to 4.10, decreasing.

39

Median gross margin 24.0% over 10y, very stable.

46

Median ROIC 11.7%, above the 12% hurdle in 50% of years.

—

Insufficient leverage/coverage inputs to score the balance sheet.

14

Owner earnings changed -6.3%/yr over up to the ten most recent annual observations.

The balanceSheet component abstained: Insufficient leverage/coverage inputs to score the balance sheet. The other four 20% weights were renormalized over the scored 80%.

Price vs. value if growth stopped today

A cautious baseline, not a price target: what the shares may support if normalized owner earnings simply hold steady.

Above value if growth stopped todayBelow value if growth stopped today
60% above value if growth stopped today
$857M
$42.52
$45.83
$68.20
60% above value if growth stopped today

What today’s price assumes: owner earnings growing ~10%/yr over 5 years. The zero-growth estimate assumes owner earnings stay flat (0% growth).

How to read this

We solve for the constant annual change in owner earnings that would make the five-year zero-growth estimate equal today’s price. This keeps the existing model inputs and calculation unchanged; it is an expectations lens, not a forecast.

This zero-growth estimate assumes trailing owner earnings persist — unreliable for declining businesses. The recent FY revenue series does not trigger the three-consecutive-declines flag.

Among the current top-score group, the median current price is 239% above the zero-growth estimate across 48 of the current top 50 companies by Moat Score with both values.

Score records captured Jul 26, 2026.

Exactly which 50 companies?

FTNT, META, MEDP, IBEX, MSFT, GOOGL, LULU, ANF, IDXX, TXRH, FHI, QLYS, FFIV, ADBE, LLY, MANH, VEEV, GRMN, SSD, MNST, DOCS, MCO, CPRT, NTAP, LRCX, NVDA, CORT, SFM, MPTI, ULTA, SN, RMD, ROL, PAYC, IRMD, INTU, DECK, MORN, LGCY, DAL, GWW, ISRG, MPWR, CTAS, LOPE, MRK, CMG, FAST, BKNG, ORLY

Missing a usable price or zero-growth estimate: ANF, BKNG.

Model details under moat-index@3.0.0: zero-growth multiple 11.1×, capped-growth comparison at no more than 18×; 9% discount rate; high-end growth 1% (capped at 4%) using min(5y revenue CAGR, 5y diluted-EPS CAGR), clamped to 0%–4%; maintenance capex uses min(capex, D&A); abstain when D&A is unavailable. This is a disclosed model range, not intrinsic value as fact.

20 years of fundamentals

The business, in plain English

EASTMAN CHEMICAL CO booked $8.8B of revenue in FY2025 in the Materials sector and kept 21.1% of it as gross profit — a moderate-margin business by that measure. After every other cost, 5.4% of each revenue dollar reached the bottom line.

Across the filed record, revenue grew from $6.8B (FY2007) to $8.8B (FY2025) — about 1.4% a year compounded over 18 years.

ROIC is not available for the latest filed year, FY2025. Across the full 11-year measurable filed record, median ROIC was 20.3%. Over the v3 recent window (2 measurable filed years), median ROIC was 11.7%. The Returns on Capital filter above scores it 46/100.

The balance sheet carried $4.8B of total debt in FY2025 against $474M of owner earnings — roughly 10.1 years of owner earnings to retire it all.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

FY2006–FY2025 · 20 fiscal years, normalized from EMN’s SEC filings

Sales, as filed$8.8B FY2025
$0$5B$10B2006201320202025
Revenue kept after cost of goods21.1% FY2025
0%20%2006201320202025
Standard ROIC or separately labeled Operating ROICROIC 13.0% FY2017
0%20%40%2006201320202025
Cash an owner could take out$474M FY2025
$0$500M$1B2006201320202025

Gaps in a line mean that item isn’t in EMN’s filings for that year. The series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Flagship explainer

How EASTMAN CHEMICAL CO makes its money

EASTMAN CHEMICAL CO's filing does not supply enough comparable lines for a truthful flow chart — here's what is filed:

Table alternative
Filed lineValue% of revenueSource
$8.8B100%
Cost of revenue$6.9B79%
$1.8B21%
Income before tax$568M6%
Income tax$93M1%
$474M5%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set

Flagship explainer

What EASTMAN CHEMICAL CO owns — and owes

EASTMAN CHEMICAL CO's filing tags don't support a full breakdown — here's what is filed:

Table alternative
Filed lineValue% of assetsSource
Total assets$14.9B100%
Cash and equivalents$566M4%
$4.8B32%
Stockholders’ equity$6.0B40%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set

Flagship explainer

What drives EASTMAN CHEMICAL CO’s return on equity?

One or more filed inputs needed for the five-factor decomposition are unavailable.

DuPont source inputs
InputValueFiscal yearSource
Net income$474MFY2025
Income before tax$568MFY2025
Operating incomeUnavailableFY2025
Revenue$8.8BFY2025
Ending assets$14.9BFY2025
Beginning assets$15.2BFY2024
Ending equity$6.0BFY2025
Beginning equity$5.8BFY2024
Source:
  • SEC filingFiling detailsAccession 0000915389-26-000013
· event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set

Flagship explainer

Where EASTMAN CHEMICAL CO's cash went

EASTMAN CHEMICAL CO’s filing does not supply enough provenance-matched cash-flow lines for a truthful flow chart — here’s what is filed:

Table alternative
Filed lineValue% of cash from operationsSource
Cash from operations$970M100%
Depreciation and amortization$513M53%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set

Curated 19-manager tier

Who reported holding EASTMAN CHEMICAL CO

Delayed public 13F reports for 2026-Q2—not live positions, trades, or recommendations.

1 holding0 exited0 not holding1/19 resolved18 unavailable

Named manager positions and quarter-over-quarter changes
ManagerReported positionQuarter-over-quarterFiling accession
Markel / Markel-Gayner74,950 shares$5M · 0% of eligible reported 13FUnchanged · 0 shares (0%)
Abrams CapitalUnavailableComparison unavailableFiling unavailable
Akre CapitalUnavailableComparison unavailableFiling unavailable
Baupost GroupUnavailableComparison unavailableFiling unavailable
Berkshire HathawayUnavailableComparison unavailableFiling unavailable
Brave Warrior AdvisorsUnavailableComparison unavailableFiling unavailable
Dodge & CoxUnavailableComparison unavailableFiling unavailable
First EagleUnavailableComparison unavailableFiling unavailable
FundsmithUnavailableComparison unavailableFiling unavailable
Gardner Russo & QuinnUnavailableComparison unavailableFiling unavailable
Gates Foundation TrustUnavailableComparison unavailableFiling unavailable
Mairs & PowerUnavailableComparison unavailableFiling unavailable
Oakmark / Harris AssociatesUnavailableComparison unavailableFiling unavailable
Pershing SquareUnavailableComparison unavailableFiling unavailable
Polen CapitalUnavailableComparison unavailableFiling unavailable
Sequoia / Ruane CunniffUnavailableComparison unavailableFiling unavailable
Southeastern Asset ManagementUnavailableComparison unavailableFiling unavailable
Tweedy, BrowneUnavailableComparison unavailableFiling unavailable
Yacktman Asset ManagementUnavailableComparison unavailableFiling unavailable

Position size uses shares and filed value from each manager’s 13F. Portfolio weight uses the eligible long-share filing denominator. Changes compare only with the immediately preceding calendar quarter.

Source: · event Jun 30, 2026 · retrieved Jul 26, 2026

Flagship explainer

What EASTMAN CHEMICAL CO insiders reported

Records still being gathered — partial as of retrieval Aug 17, 2026.

Partial coverage: the incomplete Form 4 walk cannot establish no activity, an activity date, or zero counts.

Moat Score history

16 logged readings since Jul 17, 2026 · append-only, never rewritten

Moat Score over timeLast scored reading of each day, on the 0–100 scale31.4 / 100
0406080100WideNarrowShallowNo moatJul 20, 2026Jul 26, 2026

Breaks in the line mark methodology or normalizer upgrades — readings across versions aren’t compared, so a level shift there isn’t a change in the business.

Tier changesSame-methodology and same-normalizer crossings of the Wide / Narrow / Shallow bars

  1. Normalizer upgraded unstamped (version unknown)moat-xbrl-normalizer@1.1.0 — readings across versions aren’t comparedJul 26, 2026
  2. Methodology upgraded moat-index@2.0.0moat-index@3.0.0 — readings across versions aren’t comparedJul 23, 2026
  3. Methodology upgraded moat-index@1.2.0moat-index@2.0.0 — readings across versions aren’t comparedJul 20, 2026

Scores are logged append-only and never overwritten — this record cannot be reconstructed retroactively, which is exactly why it’s worth keeping.

Insider activity

Form 4 reports mix P/S market or private transactions with compensation-plan mechanics. Activity casually described as “insider selling” can include compensation mechanics; awards, tax withholding, and option exercises are shown by their exact filed class here, never collapsed into “Bought” or “Sold.”

These are disclosed filing facts and arithmetic aggregates, not a signal or verdict.

This machine-readable surface covers SEC ownership filings from 2003; it does not represent earlier paper-era records.

Records still being gathered — partial as of retrieval Aug 17, 2026.

127 filings were skipped because the SEC primary document returned 404; the omission is disclosed and aggregates are withheld.

Trailing-12-month totals and the 90-day cluster result are withheld because this issuer walk is incomplete.

InsiderShares owned afterDateFiling detail
Holt Adrian JamesSVP, Chf HR OfcrOpen-market or private sale (S)Table I · Disposed · Common Stock3,283$71.31$234,1110Aug 4, 2026
1 filed lot
  • Table I · Common Stock: 3,283 shares at $71.31 · code S · owned after 0 ·

Source-event as of . Retrieved .

Materials context

#218 of 309 scored Materials companies, ranked by Moat Score.

Nearest peers by Moat Score

  1. #216PED PEDEVCO CORP.31.6No moat
  2. #217DD DUPONT DE NEMOURS, INC.31.5No moat
  3. #219PROP Prairie Operating Co.31.4No moat
  4. #220BDCO BLUE DOLPHIN ENERGY CO31.1No moat

Compare EMN with its nearest peers →All Materials companies on the Index →

Common questions about EMN

Does EASTMAN CHEMICAL CO have an economic moat?
Based on its FY2025 SEC filings, the Moat Index scores EASTMAN CHEMICAL CO (EMN) 31.4 out of 100 — below the Shallow-moat bar, so no moat. The five questions behind that score begin at 20% each; if exactly one genuinely lacks data, the other four weights are renormalized and disclosed. revenue and EPS trend 26, pricing power 39, returns on capital 46, balance-sheet safety not measurable from the filings, capital allocation 14.
Is EMN trading below the conservative owner-earnings estimate?
The value if growth stopped today — a zero-growth baseline — is $42.52 per share. It capitalizes normalized owner earnings at a 9% rate and assumes 0% growth. Versus a recent price of $68.20, that is 60% above value if growth stopped today. The model also publishes a capped-growth comparison, but the zero-growth estimate is the cautious baseline. It assumes trailing owner earnings persist and is unreliable for declining businesses. This is an educational estimate from primary SEC filings, not intrinsic value as a fact or investment advice.
How has EMN's Moat Score changed over time?
The record logs 16 readings since Jul 17, 2026; the latest reads 31.4 out of 100 (no moat). No tier changes on record yet. (Methodology or normalizer upgrades on Jul 20, 2026, Jul 23, 2026, Jul 26, 2026 re-based the score; readings across versions aren't compared.) The history is append-only — readings are only ever added, never rewritten.

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell EMN. See the disclaimer.